Nextech Invest

Nextech Invest is a Zurich-based venture capital and private equity firm established in 1998, specializing in early, mid-stage, and late-stage investments within the healthcare and life sciences sectors. The firm focuses on companies developing innovative therapies, diagnostics, medical technologies, and services, with a particular emphasis on oncology. Nextech Invest seeks evidence of efficacy in preclinical animal models or device prototypes that meet specific requirements before considering investments. It primarily targets investments ranging from CHF 1 million to CHF 5 million per financing round and aims to secure a Board position in its portfolio companies. The firm is interested in global opportunities, particularly in Africa, the Middle East, Asia, North America, and Europe, including Germany and Switzerland, and it is open to co-investments across the rest of Europe. Nextech Invest typically aims for exit strategies within three years through trade sales.